| Literature DB >> 35854201 |
Hasan Banitalebi1,2, Jørn Aaen3,4, Kjersti Storheim5, Anne Negård6,7, Tor Åge Myklebust8,9, Margreth Grotle5,10, Christian Hellum11, Ansgar Espeland12,13, Masoud Anvar14, Kari Indrekvam13,15, Clemens Weber16,17, Jens Ivar Brox18, Helena Brisby19,20, Erland Hermansen3,21.
Abstract
BACKGROUND: Fatty infiltration of the paraspinal muscles may play a role in pain and disability in lumbar spinal stenosis. We assessed the reliability and association with clinical symptoms of a method for assessing fatty infiltration, a simplified muscle fat index (MFI).Entities:
Keywords: Magnetic resonance imaging; Paraspinal muscles; Patient-reported outcome measures; Psoas muscles; Spinal stenosis
Mesh:
Year: 2022 PMID: 35854201 PMCID: PMC9296716 DOI: 10.1186/s41747-022-00284-y
Source DB: PubMed Journal: Eur Radiol Exp ISSN: 2509-9280
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
• Age between 18 and 80 years • Clinical symptoms of LSS • Not responding to at least 3 months of non-surgical treatment • Radiological findings (foraminal, central canal, or lateral recess stenosis) corresponding to the clinical symptoms such as back pain, leg pain, or neurologic claudication • Understanding the Norwegian language (spoken and written) | • Previous surgery at the level of stenosis • Previous fracture or fusion of the thoraco-lumbar spine • Cauda equina syndrome (bowel or bladder dysfunction) or fixed complete motor deficit • ASA grade 4 or 5 • More than 20° lumbosacral scoliosis • Distinct symptoms in lower limbs due to other diseases • Stenosis in more than three lumbar levels • Being unable to comply fully with the protocol • Isthmic defect in pars interarticularis at the level of stenosis • Participation in another clinical study that could interfere with the present trial • Alcohol or substance abuse • ≥ 3 mm spondylolisthesis verified on upright lateral view x-ray • Axial T2-weighted MR images not covering the paraspinal and the psoas muscles at both sides of the spine or angulated more than 5° to the upper endplate of the vertebra at the level of measurement |
ASA American Society of Anesthesiologists, LSS Lumbar spinal stenosis
Fig. 1The flowchart shows the patient selection process. SST Spinal stenosis trial, NORDSTEN Norwegian degenerative spondylolisthesis and spinal stenosis
Fig. 2Axial T2-weighted magnetic resonance image obtained at the level of the upper endplate of L3. The muscle fat index (MFI) was calculated by dividing the mean signal intensity of the psoas major (PM) with the mean signal intensity of the erector spinae (ES) and the multifidus (MF) muscles
Patient characteristics and distribution of MRI findings
| Patient characteristics ( | Mean ± standard deviation/count (%) |
|---|---|
| Age (years) | 66.6 ± 8.5 |
| Female | 119 (49) |
| BMI | 27.8 ± 4.0 |
| Smokers | 55 (23) |
| DSCA < 75 mm2 | |
L2/L3 L3/L4 L4/L5 | 31 (19) 106 (44) 157 (65) |
| ODI score (100-point scale) | 40.66 ± 14.57 |
| NRS back pain (10-point scale) | 6.28 ± 2.19 |
| NRS leg pain (10-point scale) | 6.38 ± 2.10 |
| ZCQ pain (5-point scale) | 3.38 ± 0.55 |
| ZCQ disability (5-point scale) | 2.58 ± 0.52 |
| MFI* | 0.53 ± 0.18 |
| GCS | |
Category 0 (grade 0) Category 1 (grade 1) Category 2 (grades 2, 3, and 4) | 119 (49) 100 (41) 24 (10) |
BMI Body mass index, DSCA Dural sac cross-sectional area, GCS Goutallier classification system, MFI Muscle fat index, NRS Numeric rating scale, ODI Oswestry disability index, ZCQ Zurich claudication score
*In one case, the value of the MFI was > 1.0, redefined as 1.0
Relationship between the MFI and the GCS
| GCS grade | Mean MFI | 95% CI |
|---|---|---|
| 0.61 | 0.54, 0.68 | |
| 0.42 | 0.39, 0.44 | |
| 0.35 | 0.32, 0.37 | |
| 0.30 | 0.26, 0.34 | |
| 0.29 | 0.23, 0.35 |
CI Confidence interval, GCS Goutallier classification system, MFI Muscle fat index
Interobserver and intraobserver reliability
| Reliability | MFI | GCS |
|---|---|---|
| ICC (95% CI) | AC1 (95% CI) | |
| 0.79 (0.70, 0.85) | 0.33 (0.27, 0.39) | |
| Observer 1 | 0.91 (0.89, 0.92) | 0.92 (0.89, 0.95) |
| Observer 2 | 0.86 (0.74, 0.91) | 0.64 (0.59, 0.70) |
| Observer 3 | 0.91 (0.89, 0.93) | 0.55 (0.49, 0.60) |
AC1 Gwet’s agreement coefficient, CI Confidence interval, GCS Goutallier classification system, ICC Intraclass correlation coefficient, MFI Muscle fat index
Fig. 3Bland-Altman plots with mean differences in measurements of the muscle fat index (MFI, solid lines) and 95% limits of agreement (dashed lines) between observers 1 and 2 (a), observers 1 and 3 (b), and observers 2 and 3 (c)
Fig. 4Bland-Altman plots with mean differences in measurements of the muscle fat index (MFI, solid lines) and 95% limits of agreement (dashed lines) for repeated measurements by observer 1 (a), observer 2 (b), and observer 3 (c)
Univariate regression analyses
| Clinical parameter | MFI | GCS* | |||||
|---|---|---|---|---|---|---|---|
| -6.90 (-17.38, 3.57) | 0.195 | 1940 | 1 | 2.65 (-3.91, 9.21) | 0.427 | 1945 | |
| 2 | 10.28 (-6.40, 26.96) | 0.226 | |||||
| -1.58 (-3.11, -0.06) | 0.042 | 973 | 1 | 0.56 (-0.40, 1.52) | 0.249 | 978 | |
| 2 | 0.66 (-1.72, 3.04) | 0.584 | |||||
| -0.41 (-2.03, 1.21) | 0.618 | 1011 | 1 | 0.86 (-0.15, 1.87) | 0.093 | 1010 | |
| 2 | 1.48 (-1.02, 3.97) | 0.245 | |||||
| -0.30 (-0.71, 0.10) | 0.136 | 388 | 1 | 0.06 (-0.20, 0.33) | 0.629 | 394 | |
| 2 | 0.35 (-0.29, 0.99) | 0.281 | |||||
| -0.25 (-0.63, 0.13) | 0.191 | 368 | 1 | 0.08 (-0.16, 0.32) | 0.514 | 370 | |
| 2 | 0.51 (-0.09, 1.11) | 0.098 | |||||
AIC Akaike information criterion, CI Confidence interval, GCS Goutallier classification system, MFI Muscle fat index, NRS Numeric rating scale, ODI Oswestry disability index, ZCQ Zurich claudication questionnaire
*For the GCS, only categories with fatty infiltration are presented. The coefficient values for the GCS show the estimates for the regression equation of categories 1 and 2, respectively, on category 0 (GCS grade 0, no fatty infiltration)
Multivariate regression analyses
| Clinical parameter | MFI | GCS* | |||||
|---|---|---|---|---|---|---|---|
| -3.74 (-14.69, 7.21) | 0.502 | 1863 | 1 | 0.10 (-5.69, 7.69) | 0.769 | 1869 | |
| 2 | 7.06 (-0.26, 23.38) | 0.395 | |||||
| -0.59 (-2.13, 0.96) | 0.455 | 913 | 1 | 0.21 (-0.70, 1.12) | 0.649 | 916 | |
| 2 | -0.23 (-244, 1.98) | 0.837 | |||||
| 0.80 (-0.84, 2.44) | 0.339 | 950 | 1 | 0.63 (-0.34, 1.60) | 0.199 | 952 | |
| 2 | 0.75 (-1.61, 3.10) | 0.533 | |||||
| -0.22 (-0.64, 0.20) | 0.205 | 364 | 1 | -0.01 (-0.26, 0.26) | 0.996 | 371 | |
| 2 | 0.24 (-0.39, 0.86) | 0.454 | |||||
| -0.01 (-0.30, 0.03) | 0.979 | 344 | 1 | 0.01 (-0.24, 0.25) | 0.972 | 347 | |
| 2 | 0.40 (-0.19, 0.99) | 0.186 | |||||
AIC Akaike information criterion, CI Confidence interval, GCS Goutallier classification system, MFI Muscle fat index, NRS Numeric rating scale, ODI Oswestry disability index, ZCQ Zurich claudication questionnaire
*For the GCS, only categories with fatty infiltration are presented. The coefficient values for the GCS show the estimates for the regression equation of categories 1 and 2, respectively, on category 0 (GCS grade 0, no fatty infiltration)